De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening

De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening

Abstract Background New cervical cancer screening guidelines recommend primary human papillomavirus (HPV) testing for women age 30–65 years. Healthcare organizations are preparing to de-implement the previous recommended strategies of Pap testing or co-testing (Pap plus HPV test) and substitute prim...

Full description

Bibliographic Details
Main Authors: Erin E. Hahn, Corrine Munoz-Plaza, Danielle E. Altman, Chunyi Hsu, Nancy T. Cannizzaro, Quyen Ngo-Metzger, Patricia Wride, Michael K. Gould, Brian S. Mittman, Melissa Hodeib, Krishnansu S. Tewari, Lena H. Ajamian, Ramez N. Eskander, Devansu Tewari, Chun R. Chao
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Implementation Science Communications
Online Access:https://doi.org/10.1186/s43058-021-00211-z

Internet

https://doi.org/10.1186/s43058-021-00211-z

Similar Items